创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Introduction to the characteristics of dual humanized models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-24 14:39
  • Views:

(Summary description)In the field of biomedical research, animal models have always been an indispensable and important tool. However, traditional animal models often fail to fully simulate human physiological and pathological processes and have certain limitations. In order to solve this problem, InnoModels Biotechnology has launched the Dual Humanized Model. The model is based on human cells and tissues, constructed through advanced bioengineering technology, with a very high degree of simulation and practicability, opening up a new path for biomedical research.

InnoModels Biotechnology: Introduction to the characteristics of dual humanized models

(Summary description)In the field of biomedical research, animal models have always been an indispensable and important tool. However, traditional animal models often fail to fully simulate human physiological and pathological processes and have certain limitations. In order to solve this problem, InnoModels Biotechnology has launched the Dual Humanized Model. The model is based on human cells and tissues, constructed through advanced bioengineering technology, with a very high degree of simulation and practicability, opening up a new path for biomedical research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-24 14:39
  • Views:
Information

In the field of biomedical research, animal models have always been an indispensable and important tool. However, traditional animal models often fail to fully simulate human physiological and pathological processes and have certain limitations. In order to solve this problem, InnoModels Biotechnology has launched the Dual Humanized Model. The model is based on human cells and tissues, constructed through advanced bioengineering technology, with a very high degree of simulation and practicability, opening up a new path for biomedical research.
1、High simulation of human physiological and pathological processes
Dual humanized model adopts human cells and tissues, and realizes a high degree of simulation of human physiological and pathological processes through precise gene editing and tissue engineering technology. Such models can not only simulate human tissues and organs in terms of morphology, structure and function, but also simulate the pathogenesis and pathological changes of human diseases. This enables researchers to gain a deeper understanding of the nature and pathogenesis of diseases, providing more accurate and effective guidance for drug development and clinical treatment.
2、Reduce the moral and ethical controversy of animal experiments
Traditional animal models often involve animal experiments, which not only involve moral and ethical controversies, but also may lead to instability and unpredictability of experimental results. The dual humanized model, on the other hand, completely avoids these problems. It uses human cells and tissues without the need for animal experiments, which meets ethical and moral requirements and can provide more accurate and reliable research results.

 


3、Improve the efficiency of drug development and clinical treatment
The dual humanized model can simulate the pathogenesis and pathological changes of human diseases, providing more accurate and effective guidance for drug development and clinical treatment. By conducting drug screening and efficacy assessment on the model, researchers can screen potential drug candidates faster and conduct in-depth research and optimization on them. This will greatly shorten the drug development cycle and improve the success and efficiency of drug development. At the same time, the dual humanized model can also provide clinicians with more accurate treatment plans, improving treatment effects and patient survival rates.
4、Promote the development of personalized medicine
With the development of gene sequencing and bioinformatics and other technologies, personalized medicine has become an important trend in the field of biomedicine. As a model that highly simulates human physiological and pathological processes, dual humanization model can provide important support for personalized medicine. By constructing dual humanized models with individual differences, researchers can conduct accurate drug screening and efficacy assessment for different individuals' disease characteristics, providing more accurate and effective guidance for personalized medicine.
5. Challenges and prospects
Despite the many advantages and potentials of dual humanized models, they still face some challenges in practical applications. For example, it takes a lot of time and resources to construct models that highly simulate human physiological and pathological processes; at the same time, dual-sourced models may still have some limitations in simulating certain complex diseases. However, with the continuous progress of bioengineering and genomics technologies, it is believed that two-person modeling will be more widely used and developed in the future.
In conclusion, as a model with a high degree of simulation of human physiological and pathological processes, the InnoModels Biotechnology Two-Human Sourcing Model opens up a new path for biomedical research. It not only reduces the moral and ethical controversies of animal experiments and improves the efficiency of drug development and clinical treatment, but also provides important support for the development of personalized medicine. Despite some challenges, it is believed that with the continuous progress of technology and the expansion of application scope, dual humanized models will play a more important role in biomedical research.

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司